ARTICLE | Clinical News
Solosec regulatory update
January 25, 2017 2:44 AM UTC
Symbiomix submitted an NDA to FDA for Solosec secnidazole to treat bacterial vaginosis. The product is an oral granule formulation of a next-generation, 5-nitroimidazole antibiotic and has Fast Track ...
BCIQ Company Profiles